InvestorsHub Logo
Followers 7
Posts 1173
Boards Moderated 0
Alias Born 11/13/2018

Re: oneragman post# 217860

Sunday, 10/06/2019 7:01:17 AM

Sunday, October 06, 2019 7:01:17 AM

Post# of 424401
It looks to me like there was precedent that because Reduce-Its as filed during ongoing citation connected to the NDA that Amarin was required to give the generics information related to the sNDA. I don't think it is a part of a broader scheme related to the FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News